يعرض 1 - 10 نتائج من 15 نتيجة بحث عن '"NuvaRing®"', وقت الاستعلام: 0.90s تنقيح النتائج
  1. 1
    دورية أكاديمية

    المساهمون: Grandi, G., Timo, A., Sammarini, M., Del Savio, M. C., Facchinetti, F.

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/31922428; info:eu-repo/semantics/altIdentifier/wos/WOS:000506516000001; volume:25; issue:1; firstpage:60; lastpage:64; journal:THE EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE; http://hdl.handle.net/11380/1201422Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85077894721

  2. 2
  3. 3
    تقرير

    المصدر: SINGLE DOSE CROSSOVER COMPARATIVE BIOAVAILABILITY STUDY OF ETHINYL ESTRADIOL/ETONOGESTREL VAGINAL RING (DELIVERING 0.015 mg/0.12 mg PER DAY) WORN FOR 21 DAYS IN HEALTHY FEMALE SUBJECTS

  4. 4
    تقرير

    المؤلفون: Organon

    المساهمون: Mitchell Creinin, MD

    المصدر: Creinin MD, Meyn LA, Borgatta L, Barnhart K, Jensen J, Burke AE, Westhoff C, Gilliam M, Dutton C, Ballagh SA. Multicenter comparison of the contraceptive ring and patch: a randomized controlled trial. Obstet Gynecol. 2008 Feb;111(2 Pt 1):267-77. doi: 10.1097/01.AOG.0000298338.58511.d1.
    An Open-Label, Randomized, Multicenter Trial to Evaluate Continuation Rates, Side Effects and Acceptability of NuvaRing Versus OrthoEvra

  5. 5
    تقرير

    المصدر: van den Heuvel MW, van Bragt AJ, Alnabawy AK, Kaptein MC. Comparison of ethinylestradiol pharmacokinetics in three hormonal contraceptive formulations: the vaginal ring, the transdermal patch and an oral contraceptive. Contraception. 2005 Sep;72(3):168-74. doi: 10.1016/j.contraception.2005.03.005.
    An Open-label, Randomized, Parallel Group Trial in Healthy Female Subjects to Compare the Pharmacokinetics of Ethinyl Estradiol of NuvaRing®, a Contraceptive Patch (EVRA(TM)) and an Oral Contraceptive (Microgynon® 30)

  6. 6
    تقرير

    المساهمون: Terhi Piltonen/M.D., Ph.D.

    المصدر: The Impact of Different Administration Routes of Hormonal Contraceptives on Androgen Synthesis, Glucose Metabolism and Inflammation. A Prospective Randomized Trial.

  7. 7
    تقرير

    المصدر: Fan GS, Ren M, Di W, Su P, Chang Q, Wu S, Qin Y, Korver T, Marintcheva-Petrova M, Yacik C, McCrary Sisk C, Wang G. Efficacy and safety of the contraceptive vaginal ring (NuvaRing) compared with a combined oral contraceptive in Chinese women: a 1-year randomised trial. Eur J Contracept Reprod Health Care. 2016 Aug;21(4):303-9. doi: 10.1080/13625187.2016.1186269. Epub 2016 Jun 24.
    A Randomized, Open-Label, Controlled, Multi-Center Trial to Evaluate the Contraceptive Efficacy, Cycle Control, Safety and Acceptability of NuvaRing® (SCH 900702) in Chinese Women

  8. 8
    تقرير

    المصدر: Contraceptive Vaginal Ring Releasing Etonogestrel and Ethinylestradiol (NuvaRing): Cycle Control, Acceptability and Tolerability Study in Indian Women

  9. 9
    تقرير
  10. 10
    دورية أكاديمية

    المساهمون: Bruni, V., Pontello, V., Luisi, S., Petraglia, F.

    مصطلحات موضوعية: Compliance, Contraception, Efficacy, NuvaRing ®, Vaginal ring

    وصف الملف: STAMPA

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/18358586; info:eu-repo/semantics/altIdentifier/wos/WOS:000258042600012; volume:139; issue:1; firstpage:65; lastpage:71; numberofpages:7; journal:EUROPEAN JOURNAL OF OBSTETRICS, GYNECOLOGY, AND REPRODUCTIVE BIOLOGY; http://hdl.handle.net/11365/3600Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-45949083693